SaVida Health
-
Services:
- Testing for Hepatitis B (HBV)
- Metabolic syndrome monitoring
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- TB screening
- HIV testing
- STD testing
- Breathalyzer or blood alcohol testing
- Naltrexone (extended-release, injectable)
- Buprenorphine with naloxone
- Disulfiram
- Buprenorphine (extended-release, injectable)
- Medications for Hepatitis C treatment
- Clonidine
- Nicotine replacement
- Medication for mental disorders
- Acamprosate (Campral®)
- Buprenorphine without naloxone
- Naltrexone (oral)
- Non-nicotine smoking/tobacco cessation
- Private for-profit organization
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- HIV or AIDS education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Hepatitis education, counseling, or support
- SAMHSA certification for opioid treatment program (OTP)
- State Substance use treatment agency
- Drug Enforcement Agency (DEA)
- State department of health
- Male
- Female
- Relapse prevention with naltrexone
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes naltrexone
- Prescribes buprenorphine
- Mental health services
- Interim services for clients
- Comprehensive mental health assessment
- Professional interventionist/educational consultant
- Screening for tobacco use
- Screening for substance use
- Screening for mental disorders
- Comprehensive substance use assessment
- Outreach to persons in the community
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Regular outpatient treatment
- Smoking permitted in designated area
- Smoking not permitted
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- This facility administers/prescribes medication for alcohol use disorder
- Adult women
- Members of military families
- Criminal justice (other than DUI/DWI)/Forensic clients
- Veterans
- Active duty military
- Clients who have experienced trauma
- Clients who have experienced sexual abuse
- Clients with co-occurring pain and substance use disorders
- Clients who have experienced intimate partner violence, domestic violence
- Young adults
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Adult men
- Clients with co-occurring mental and substance use disorders
- Clients with HIV or AIDS
- Seniors or older adults
- Pregnant/postpartum women
- Sliding fee scale (fee is based on income and other factors)
- Vaping permitted in designated area
- Vaping not permitted
- Contingency management/motivational incentives
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Brief intervention
- Relapse prevention
- Young Adults
- Adults
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Medicaid
- Private health insurance
- Medicare
- SAMHSA funding/block grants
- Federal military insurance (e.g., TRICARE)
- State-financed health insurance plan other than Medicaid
- Cash or self-payment
- No formal relationship with prescribing entity
Testing
Pharmacotherapies
Facility Operation (e.g., Private, Public)
Education and Counseling Services
License/Certification/Accreditation
Gender Accepted
Type of Opioid Treatment
Ancillary Services
Assessment/Pre-treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Smoking Policy
Opioid Medications used in Treatment
Transitional Services
Type of Alcohol Use Disorder Treatment
Special Programs/Groups Offered
Payment Assistance Available
Facility Vaping Policy
Treatment Approaches
Age Groups Accepted
Type of Care
Payment/Insurance/Funding Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
